NIO
NIO Inc.
NIO has a slight edge over SBH overall, supported by stronger fundamentals and stronger valuation.
SBH
Sally Beauty Holdings, Inc.
SBH has slightly lower modeled downside risk, despite its lower overall score.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
SBH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
SBH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
SBH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $12.33 | -33% |
| Fair | 7.9x | $15.93 | -13% |
| Forward | 8.2x | $18.41 | — |
| Current | 9.1x | $18.41 | — |
| Expensive | 9.8x | $19.70 | +7% |
Historical ranges are pointers, not guarantees.
SBH's PE is in its expensive range at 9.1x. If earnings grow as analysts expect, today's price would be 8.2x next year's earnings, in its fair range.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over SBH on the outlook, with more favorable revenue expectations.
SBH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect SBH's earnings to grow and its profitability to improve, with its revenue holding steady.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
SBH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.26 | +12% |
| Q3 2026 | $2.02 | +6.9% |
| Q2 2026 | $1.92 | +3.8% |
| Q1 2026 | $1.81 | +2.3% |
| Q4 2025 | $1.76 | +6% |
| Q3 2025 | $1.89 | +32% |
| Q2 2025 | $1.85 | +34% |
| Q1 2025 | $1.77 | +20% |
| Q4 2024 | $1.66 | +5.1% |
SBH has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over SBH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
SBH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $952.5M | +0.6% |
| Q2 2026 | $935.5M | +0.2% |
| Q1 2026 | $903.4M | +2.3% |
| Q4 2025 | $943.2M | +0.6% |
| Q3 2025 | $947.1M | +1.3% |
| Q2 2025 | $933.3M | -1% |
| Q1 2025 | $883.1M | -2.8% |
| Q4 2024 | $937.9M | +0.7% |
SBH's revenue has held roughly level: $953M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.7% | +1.2 points |
| Q2 2026 | 9.2% | +0.9 points |
| Q1 2026 | 8% | +0.1 points |
| Q4 2025 | 8.1% | -2.6 points |
| Q3 2025 | 8.4% | -0.4 points |
| Q2 2025 | 8.4% | +0.8 points |
| Q1 2025 | 7.9% | +1.3 points |
| Q4 2024 | 11% | +3.3 points |
SBH has the edge over NIO on profitability, with a higher operating margin.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
SBH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $46.9M | -40% |
| Q2 2026 | $61.6M | +25% |
| Q1 2026 | $44.1M | +37% |
| Q4 2025 | $57.5M | +329% |
| Q3 2025 | $78M | +6.4% |
| Q2 2025 | $49.1M | +71% |
| Q1 2025 | $32.2M | +41% |
| Q4 2024 | $13.4M | -35% |
SBH has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
SBH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +902K shares |
| 1 year | -4.8% | -5M shares |
| 3 years | -9.6% | -10.5M shares |
| 5 years | -13% | -15.4M shares |
| Available history | -16% | -18.3M shares |
SBH has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $41.9M |
| Q2 2026 | $25.6M |
| Q1 2026 | $25.6M |
| Q4 2025 | $20.8M |
| Q3 2025 | $20.7M |
| Q2 2025 | $13.2M |
| Q1 2025 | $10.2M |
| Q4 2024 | $9.9M |
SBH spent $114M buying back its own shares over the past year, up 111% from the year before.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SBH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 2.0x | Healthy |
SBH's net debt is about 1.5 years of its operating earnings (EBITDA), down from 1.7 years a year ago.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
SBH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 72.0 | Neutral |
SBH's weekly RSI is 65 (neutral) and its Stochastic is 72 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
SBH PE vs Consumer Cyclical Sector
| Metric | SBH | Sector median | Relative |
|---|---|---|---|
| PE | 9.1x | 18x | 49% below |
| PE % | 76 | 47 | 29 pts above |
SBH is trading at 9.1x earnings, a 49% discount to the Consumer Cyclical sector's median of 18x.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
SBH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.3 | 6.5% above |
| 20 week MA | $16.4 | 13% above |
| 50 week MA | $15.2 | 21% above |
| 100 week MA | $13.2 | 39% above |
| 200 week MA | $12.6 | 46% above |
SBH has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.
SBH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.1 | $12.7 | -30% |
| 2021 | $12.7 | $18.6 | +47% |
| 2022 | $18.6 | $12.5 | -33% |
| 2023 | $12.5 | $13.3 | +6.4% |
| 2024 | $13.3 | $10.8 | -18% |
| 2025 | $10.8 | $15.0 | +38% |
| 2026 YTD | $15.0 | $18.4 | +23% |
SBH has the edge over NIO on returns for 2026, with the stronger performance.